Literature DB >> 10225871

Immune responses induced in cattle by virulent and attenuated Mycobacterium bovis strains: correlation of delayed-type hypersensitivity with ability of strains to grow in macrophages.

D N Wedlock1, F E Aldwell, D M Collins, G W de Lisle, T Wilson, B M Buddle.   

Abstract

Comparison of immune responses induced in cattle by virulent and attenuated strains of Mycobacterium bovis will assist in identifying responses associated with resistance or susceptibility to disease. Four strains of M. bovis, one which is virulent in guinea pigs (WAg201) and three which are attenuated in guinea pigs (an isoniazid-resistant strain [WAg405], ATCC 35721, and BCG) were compared for their abilities to induce immune responses in cattle and to grow in bovine lung alveolar macrophage cultures. Extensive macroscopic lesions were found only in cattle inoculated with the virulent M. bovis strain. Strong antibody responses to M. bovis culture filtrate, as well as persistently high levels of gamma interferon and interleukin-2 released from purified protein derivative (PPD)-stimulated peripheral blood lymphocyte cultures, were observed in the cattle inoculated with the virulent strain compared to those inoculated with the attenuated strains. All cattle inoculated with the virulent strain or two of the attenuated strains (WAg405 and ATCC 35721) elicited strong delayed-type hypersensitivity responses to PPD in skin tests, while animals inoculated with BCG induced only a weak response. The three strains which produced strong skin test responses proliferated well in bovine alveolar macrophages and induced high levels of proinflammatory cytokine mRNAs compared to BCG. Our study showed that skin test responsiveness to PPD correlated with the ability of the strains to grow in alveolar macrophages rather than to their pathogenicity in cattle.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225871      PMCID: PMC115954          DOI: 10.1128/IAI.67.5.2172-2177.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Bacterial metabolism, cytokine mRNA transcription and viability of bovine alveolar macrophages infected with Mycobacterium bovis BCG or virulent M. bovis.

Authors:  F E Aldwell; D N Wedlock; B M Buddle
Journal:  Immunol Cell Biol       Date:  1996-02       Impact factor: 5.126

2.  Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro.

Authors:  S Paul; P Laochumroonvorapong; G Kaplan
Journal:  J Infect Dis       Date:  1996-07       Impact factor: 5.226

3.  Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex.

Authors:  D M Collins; R P Kawakami; G W de Lisle; L Pascopella; B R Bloom; W R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

4.  A sandwich enzyme immunoassay for bovine interferon-gamma and its use for the detection of tuberculosis in cattle.

Authors:  J S Rothel; S L Jones; L A Corner; J C Cox; P R Wood
Journal:  Aust Vet J       Date:  1990-04       Impact factor: 1.281

5.  Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis.

Authors:  J Vilcek; A Klion; D Henriksen-DeStefano; A Zemtsov; D M Davidson; M Davidson; A E Friedman-Kien; J Le
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

6.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

7.  A field evaluation of serological and cellular diagnostic tests for bovine tuberculosis.

Authors:  P R Wood; L A Corner; J S Rothel; J L Ripper; T Fifis; B S McCormick; B Francis; L Melville; K Small; K de Witte
Journal:  Vet Microbiol       Date:  1992-04       Impact factor: 3.293

8.  ELISA tests for antibodies in experimental bovine tuberculosis.

Authors:  J Hanna; S D Neill; J J O'Brien
Journal:  Vet Microbiol       Date:  1992-06-01       Impact factor: 3.293

9.  Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.

Authors:  G G Mahairas; P J Sabo; M J Hickey; D C Singh; C K Stover
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490

10.  Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis.

Authors:  T M Wilson; G W de Lisle; D M Collins
Journal:  Mol Microbiol       Date:  1995-03       Impact factor: 3.501

View more
  15 in total

1.  Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis.

Authors:  D N Wedlock; B Vesosky; M A Skinner; G W de Lisle; I M Orme; B M Buddle
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.

Authors:  D Neil Wedlock; Michel Denis; Margot A Skinner; Jessica Koach; Geoffrey W de Lisle; H Martin Vordermeier; R Glyn Hewinson; Sylvia van Drunen Littel-van den Hurk; Lorne A Babiuk; Rolf Hecker; Bryce M Buddle
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis.

Authors:  Margot A Skinner; D Neil Wedlock; Geoffrey W de Lisle; Michèle M Cooke; Ricardo E Tascon; Jose C Ferraz; Douglas B Lowrie; H Martin Vordermeier; R Glyn Hewinson; Bryce M Buddle
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

4.  In vitro T-cell activation of monocyte-derived macrophages by soluble messengers or cell-to-cell contact in bovine tuberculosis.

Authors:  E Liebana; A Aranaz; M Welsh; S D Neill; J M Pollock
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

5.  Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin.

Authors:  M A Chambers; A Williams; D Gavier-Widén; A Whelan; G Hall; P D Marsh; B R Bloom; W R Jacobs; R G Hewinson
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Mycobacterium bovis-infected cervine alveolar macrophages secrete lymphoreactive lipid antigens.

Authors:  F E Aldwell; B L Dicker; F M da Silva Tatley; M F Cross; S Liggett; C G Mackintosh; J F Griffin
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

7.  Cytotoxic T-cell responses to Mycobacterium bovis during experimental infection of cattle with bovine tuberculosis.

Authors:  Margot A Skinner; Natalie Parlane; Allison McCarthy; Bryce M Buddle
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

8.  Immune responses in cattle inoculated with Mycobacterium bovis, Mycobacterium tuberculosis, or Mycobacterium kansasii.

Authors:  W R Waters; A O Whelan; K P Lyashchenko; R Greenwald; M V Palmer; B N Harris; R G Hewinson; H M Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2009-12-09

9.  Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination.

Authors:  B M Buddle; D N Wedlock; N A Parlane; L A L Corner; G W De Lisle; M A Skinner
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Interleukin-1beta infusion in bovine mammary glands prior to challenge with Streptococcus uberis reduces bacterial growth but causes sterile mastitis.

Authors:  D Neil Wedlock; Michel Denis; Jane Lacy-Hulbert; Bryce M Buddle
Journal:  Vet Res Commun       Date:  2008-04-19       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.